These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 462379)

  • 1. A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma.
    Balch CM; Soong SJ; Murad TM; Ingalls AL; Maddox WA
    Surgery; 1979 Aug; 86(2):343-51. PubMed ID: 462379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
    Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA
    Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia.
    Balch CM; Soong SJ; Milton GW; Shaw HM; McGovern VJ; Murad TM; McCarthy WH; Maddox WA
    Ann Surg; 1982 Dec; 196(6):677-84. PubMed ID: 7149819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).
    Balch CM; Soong SJ; Murad TM; Smith JW; Maddox WA; Durant JR
    J Clin Oncol; 1983 Feb; 1(2):126-34. PubMed ID: 6668496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II).
    Balch CM; Soong SJ; Murad TM; Ingalls AL; Maddox WA
    Ann Surg; 1981 Mar; 193(3):377-88. PubMed ID: 7212800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
    Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
    Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment.
    Urist MM; Balch CM; Soong SJ; Milton GW; Shaw HM; McGovern VJ; Murad TM; McCarthy WH; Maddox WA
    Ann Surg; 1984 Dec; 200(6):769-75. PubMed ID: 6508408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcopenia as a prognostic factor among patients with stage III melanoma.
    Sabel MS; Lee J; Cai S; Englesbe MJ; Holcombe S; Wang S
    Ann Surg Oncol; 2011 Dec; 18(13):3579-85. PubMed ID: 21822551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
    Statius Muller MG; van Leeuwen PA; de Lange-De Klerk ES; van Diest PJ; Pijpers R; Ferwerda CC; Vuylsteke RJ; Meijer S
    Cancer; 2001 Jun; 91(12):2401-8. PubMed ID: 11413531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma.
    Reintgen DS; Cox EB; McCarty KS; Vollmer RT; Seigler HF
    Ann Surg; 1983 Sep; 198(3):379-85. PubMed ID: 6615058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study.
    Barnhill RL; Fine JA; Roush GC; Berwick M
    Cancer; 1996 Aug; 78(3):427-32. PubMed ID: 8697387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morphological prognostic criteria in skin melanoma].
    Parshikova SM; Khasanov ShR
    Vopr Onkol; 1991; 37(3):283-8. PubMed ID: 2031322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of patients with pathologic stage II cutaneous malignant melanoma.
    Roses DF; Provet JA; Harris MN; Gumport SL; Dubin N
    Ann Surg; 1985 Jan; 201(1):103-7. PubMed ID: 3966826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical management of regional lymph nodes in cutaneous melanoma.
    Balch CM
    J Am Acad Dermatol; 1980 Nov; 3(5):511-24. PubMed ID: 7217379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Survival analysis in patients with cutaneous malignant melanoma].
    Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
    Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage I cutaneous malignant melanoma: risk factors of loco-regional recurrence after wide local excision and clinical perspectives.
    Bachaud JM; Shubinski R; Boussin G; Chevreau C; David JM; Viraben R; Bonafé JL; Daly NJ
    Eur J Surg Oncol; 1992 Oct; 18(5):442-8. PubMed ID: 1426294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY; Tufaro AP; Manson PN
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is sentinel lymph node biopsy of therapeutic relevance for melanoma?
    Möhrle M; Schippert W; Rassner G; Garbe C; Breuninger H
    Dermatology; 2004; 209(1):5-13. PubMed ID: 15237261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.